The Joint Blog

NOVEMBER 8, 2020

mg of CBD (both very low numbers). The study concludes by stating that “To our knowledge, this is the first randomized controlled trial to demonstrate the benefit of cannabis oil – a THC-rich whole plant extract – on symptoms and on [the] quality of life of people with fibromyalgia. On average patients received 3.6 mg of THC and 0.08

Clinical Trials 49

Clinical Trials Oil Therapy Marijuana 49

Cannabis Law Report

SEPTEMBER 13, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood. No approved TNF inhibitor has ever been dosed orally.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. CBD for hypertension. Related story Can CBD Help Your Condition? The results were mixed.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

PrestoDoctor

OCTOBER 11, 2023

One area of research that has been gaining attention is the use of CBD-rich cannabis in treating the social symptoms of Autism Spectrum Disorder (ASD). Studies have shown that CBD-rich cannabis can help alleviate symptoms such as anxiety, aggression, and social isolation in individuals with ASD. What is CBD?

CBD 52

CBD Research and Development Clinical Trials Treatment 52

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. CBD for hypertension. Related story Can CBD Help Your Condition? The results were mixed.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Cannabis Law Report

OCTOBER 19, 2021

will discuss the multiple indications for each of MyMD’s novel drug candidates, MYMD-1 and Supera-CBD. Unlike other therapies, MYMD-1 has been shown to selectively block TNF-? About Supera-CBD. A vast majority of CBD developers are pursuing compounds targeted to CB2 that have minimal CB1 affinity. About MYMD-1.

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Chronic Pain 52

Cannabis Law Report

SEPTEMBER 9, 2021

MyMD to highlight its development pipeline for MYMD-1, an immunometabolic regulator, and Supera-CBD, a synthetic cannabidiol derivative. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, will present at the H.C. For more information, visit www.mymd.com.

Pharmaceutical 97

Pharmaceutical Clinical Trials Chronic Pain Epilepsy 97

TheAnswerPage

APRIL 27, 2020

Is the US VA Office of research and Development conducting any clinical trials that evaluate the use of CBD for the treatment of PTSD? A RCT evaluating the efficacy of using CBD as an adjunctive to prolonged exposure therapy (PE therapy)) was started in March 2019 and will conclude on September 30,2023.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Canna Law Blog

JANUARY 22, 2020

The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post back in 2018. In that post, I explained how the Food and Drug Administration (FDA) approval process works and why this trial is so interesting and important. Psilocybin!

Clinical Trials 116

Clinical Trials Decriminalization Microdosing Food 116

Cannabis Law Report

JUNE 20, 2021

The CIC consists of 97 members dedicated to ensuring a greater understanding of the role of medicinal cannabis, nutraceutical CBD, and hemp across the community and the advancement of medicinal cannabis as an alternate line of therapy. Patient access.

Supply Chain 105

Supply Chain Clinical Trials Research and Development Medicine 105

Canna Care Docs

OCTOBER 3, 2023

Natural plant therapy , and cannabis specifically, has been studied for its effectiveness in alleviating and treating many of these physiological and emotional symptoms that come into play with a terminal illness. One study from the Journal of Clinical Oncology examined the efficacy of cannabinoids in appetite stimulation.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

PrestoDoctor

SEPTEMBER 15, 2023

While there are a variety of treatments available, many individuals do not find relief with traditional medications or therapies. However, exploring alternative treatment options, such as CBD , alongside traditional therapies can offer individuals with OCD a potential avenue for relief and improved symptom management.

Research and Development 105

Research and Development Therapy Treatment Strains 105

TheAnswerPage

FEBRUARY 23, 2022

What are the common adverse events noted in clinical trials examining the efficacy of cannabinoids for ASD? These adverse events were similar the adverse events in the trials examining the efficacy of CBD for the treatment of seizures. Some of these studies have shown positive results, but adverse events were also noted.

Clinical Trials 52

Clinical Trials Events Therapy Sleep 52

Miss Marijuana

MAY 13, 2020

Have you ever asked yourself, “How Much CBD should I take?” If so, here’s what a real life cannabis coach has to say about CBD dosage. Cannabidiol (CBD) is flooding the market and everyone seems to be talking about it. Are you curious about trying CBD? How much CBD should you take and how often? Choosing products.

CBD 98

CBD Blood Pressure Clinical Trials Tincture 98

MedicalJane

JUNE 29, 2018

On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). ” Using CBD Oil To Treat Seizures. Use of CBD in seizure prevention is well-documented with research ; and now, after conducting its own trials, the FDA appears to agree. The Next Move Is On The DEA.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Law Report

SEPTEMBER 22, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced new data demonstrating Supera-CBD’s superior potency over CBD by factor of 8,000 times. Watch how Supera-CBD works. “We Chief Scientific Officer of MyMD. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

NOVEMBER 25, 2021

CBD is all the rage, and has been for quite some time. Most cannabis by-products are legal these days, and the CBD industry has been booming. Here are a few reasons why CBD products are more popular than ever this year. However, hope in the form of CBD seems to be on the way. Epilepsy Treatment. Ease Opioid Addiction.

CBD 52

CBD Clinical Trials Epilepsy Chronic Pain 52

FloridaMarijuana.net

AUGUST 15, 2018

While PTSD can be treated with therapies and pharmaceutical medications, those are not always successful and additional treatments are necessary. The compounds THC (tetrahydrocannabinol) and CBD (cannabidiol) found in cannabis signal the same cannabinoid receptors as anandamide.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

CannaMD

MAY 25, 2021

In recent years, research has revealed that two of marijuana’s two major cannabinoids — THC and CBD — can interact with the human endocannabinoid system to influence bone healing and regeneration. THC, CBD & THE ECS. CBD PROMOTES BONE GROWTH. CBD alone is sufficiently effective in enhancing fracture healing.

Marijuana 111

Marijuana Research and Development Clinical Trials THC 111

TheAnswerPage

FEBRUARY 3, 2020

Is the US VA Office of research and Development conducting any clinical trials that evaluate the use of CBD for the treatment of PTSD? A RCT evaluating the efficacy of using CBD as an adjunctive to prolonged exposure therapy (PE) was started in March 2019 and will conclude on September 30,2023.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Weedistry

MARCH 7, 2019

A team of Spanish scientists led by Manuel Guzman conducted the first clinical trial assessing the antitumoral action of THC on human beings. Guzman administered pure THC via a catheter into the tumors of nine hospitalized patients with glioblastoma, who had failed to respond to standard brain-cancer therapies.

THC 40

THC CBD Clinical Trials Research and Development 40

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. So sit back, relax – and if you can’t relax, grab some CBD! What is CBD? Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol.

CBD 99

CBD DEA Research and Development Hemp 99

Cannabis Law Report

MAY 10, 2022

This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. However senior author Dr Elizabeth Cairns said the current evidence base for medicinal cannabis for anxiety is limited to only a few studies investigating CBD-dominant products, rather than THC-containing products.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. The longitudinal study showed that individuals who used artisanal cannabidiol (CBD) products reported better quality of life, lower psychiatric symptom severity and fewer medication-related adverse events compared with those not using CBD.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

MMJ Recs

NOVEMBER 30, 2023

The two most well-known compounds in cannabis are tetrahydrocannabinol (THC) and cannabidiol (CBD), each of which has distinct effects on the human body. Studies have indicated that certain cannabinoids found in cannabis, particularly CBD, may have anticonvulsant properties.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

Cannabis Law Report

DECEMBER 1, 2021

MyMD to highlight its development pipeline for two novel therapeutics: immune regulator MYMD-1 and synthetic cannabidiol derivative Supera-CBD. During the conferences, MyMD executives will discuss the multiple indications being pursued and market opportunities for novel drug candidates MYMD-1 and Supera-CBD. About Supera-CBD.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. Orphan Drug Designation?

DEA 66

DEA Clinical Trials THC Research and Development 66

MMJ Recs

DECEMBER 28, 2023

Strains with a balanced THC and CBD ratio are often recommended for their synergistic effects in pain relief without the intense psychoactive experience. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects. Medical cannabis, with its anxiolytic properties, offers a potential solution.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

CannaMD

JUNE 2, 2021

Of those states that had legalized medical marijuana, 14 currently consider Parkinson’s disease a qualifying condition for medical marijuana therapies. A quarter of all users did not know the strain or THC/CBD content of the product they were using. Florida is among these states.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

MMJ Recs

NOVEMBER 20, 2023

While there are over 100 different cannabinoids identified in cannabis, the two most well-known and widely studied are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). On the other hand, CBD is non-psychoactive and has gained attention for its potential therapeutic applications.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

The Cannigma

JUNE 24, 2021

Countless people now use CBD and other hemp-derived products as part of a prescribed medical regimen, as a daily health supplement, or just a go-to panacea to make the stress of daily life a little bit easier to manage. That doesn’t mean that CBD or other cannabis products should be seen as a cure all on their own.

CBD 75

CBD Microdosing Edibles Sleep 75

Cannabis Law Report

MAY 29, 2022

FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications. More recently, MDMA therapy has inched closer to FDA approval. Clinical Trials and Human Subject Protections.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Otherside Farms

APRIL 30, 2019

CBD oil is an option. Learn more about CBD oil for stress and anxiety here. We’re talking about CBD. We are going to break down how you can use CBD oil for stress and anxiety and some of the incredible research and scientific evidence backing it up. Why Use CBD Oil for Stress or Anxiety? Let’s begin!

Oil 70

Oil CBD Blood Pressure Clinical Trials 70

Veriheal

APRIL 11, 2022

I look forward to a time when they are not considered alternative therapies or home remedies but actually first-line therapies,” said the CEO of Zelira, Oludare Odumosu. “We Additionally, numerous other cannabis-based medications have already gained approval or are in the process of being tested in clinical trials.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

The Cannigma

FEBRUARY 2, 2021

However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD. Patients can also access CBD products without a prescription through local pharmacies. Still, research is ongoing.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

The Joint Blog

JANUARY 12, 2020

The market for CBD pet products has exploded in recent years, with numerous success stories. However, researchers warn that not only are not all CBD pet products made equally, but some contain no CBD at all. Because the federal government has yet to establish standards for CBD, these companies can get away with it.

Pets 36

Pets CBD Clinical Trials Research and Development 36